Clinical trial
Strategic Timing of AntiRetroviral Treatment
NCT00867048 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strategic Timing of AntiRetroviral Treatment
- Lead sponsor
- University of Minnesota
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 15, 2009
- Completion date
- July 27, 2022
- Enrollment
- 4,688 (actual)
- Sites
- 218
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection